Clinical Trials Directory

Trials / Completed

CompletedNCT03525626

Online Mindfulness-based Tic Reduction

Online Mindfulness-based Tic Reduction: Development and Testing (Phase One)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Bowdoin College · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of individuals either do not respond to the current treatments, find them unacceptable, or cannot access them. Thus, it is essential that researchers continue to pursue novel treatment approaches that can also be easily disseminated to those in need. Initial pilot data suggest that a mindfulness-based intervention may be beneficial for adults with tic disorders. In the present study, the researchers aim to further develop this mindfulness-based intervention, adapt it to be delivered online and pilot test the intervention with a small group of participants. The data from this pilot test will inform a subsequent randomized controlled trial comparing online mindfulness-based tic reduction to online psychoeducation, relaxation, and supportive therapy. The specific aim is to determine the feasibility and acceptability of Online Mindfulness-based Tic Reduction in 6 adults with TS or PTD. The researchers hypothesize that Online Mindfulness-based Tic Reduction will be feasible and acceptable to adults with tic disorders as measured by participant satisfaction, qualitative participant feedback, home practice compliance, dropout, and adverse events.

Conditions

Interventions

TypeNameDescription
BEHAVIORALOnline Mindfulness-based Tic Reduction8-week online group mindfulness-based intervention for tics

Timeline

Start date
2018-04-04
Primary completion
2018-08-07
Completion
2018-08-07
First posted
2018-05-15
Last updated
2019-07-09

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03525626. Inclusion in this directory is not an endorsement.